Original Literature | Model OverView |
---|---|
Publication
Title
Mechanisms of selection mediated by interleukin-7, the preBCR, and hemokinin-1during B-cell development.
Affiliation
Princess Margaret Hospital, Toronto, ON, Canada. cmline@uhnres.utoronto.ca
Abstract
Many of the stromal-derived signals and factors that regulate B lymphopoiesishave been identified. We review recent evidence from our laboratory that showsthat there are at least three phases during B-cell development when cells directtheir own maturation, independent of stromal cells. Following the expression ofthe preB-cell receptor (preBCR), cells acquire the ability to proliferate in lowlevels of interleukin-7 (IL-7), which acts as a self-selecting mechanism toexpand cells that have successfully expressed a preBCR in environments that arenon-permissive to preBCR- cells. Second, the preBCR is required for acontact-mediated event between B-cell progenitors. Disruption at this stageprevents the further maturation of progenitors to the lipopolysaccharide(LPS)-responsive stage. Finally, the transition from IL-7 receptor to matureantigen receptor-based signaling is enhanced by a novel member of the tachykininfamily, hemokinin-1. This series of maturation, survival, and differentiationsignals is generated by B-lineage cells as they progress through developmentalcheckpoints on the way to becoming functionally mature cells.
PMID
14962188
|
Entity
PI3K {activated}
--
MO000000030
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m31
10
infinite
0
TRANSPATH | MO000000030 |
--
IL-7
--
MO000016830
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1767
10
infinite
0
InterPro | IPR001181 |
TRANSPATH | MO000016830 |
--
tachykinin receptors
--
MO000018418
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3056
10
infinite
0
TRANSPATH | MO000018418 |
--
hk1
--
MO000023541
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m7316
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000023541 |
--
syndecan-4
--
MO000089931
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m63496
10
infinite
0
TRANSPATH | MO000089931 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
heparan {activated}
--
e13
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m11
0
infinite
0
--
heparin {activated}
--
e14
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m14
10
infinite
0
TRANSPATH | MO000018926 |
--
csml-variable:Double
m16
0
infinite
0
--
heparan sulphate
--
e16
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m15
0
infinite
0
--
csml-variable:Double
m19
0
infinite
0
--
lambda5: VpreB: Igalpha: Igbeta: preBCR
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
IL-7{extracellular}
--
e20
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m21
10
infinite
0
InterPro | IPR001181 |
TRANSPATH | MO000016830 |
--
IL-7: IL-7R
--
e21
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m22
0
infinite
0
--
preBCR{activated}
--
e22
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m23
10
infinite
0
TRANSPATH | MO000017690 |
--
heparan
--
e23
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m24
0
infinite
0
--
IL-7: IL-7Ralpha: lambdac
--
e26
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m27
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
Ras {activated}
--
e31
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m33
0
infinite
0
--
Ras
--
e32
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m34
0
infinite
0
--
csml-variable:Double
m37
0
infinite
0
--
heparan sulphate: SLC: lambda5: VpreB: Igalpha: Igbeta: preBCR
--
e36
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m38
0
infinite
0
--
galectin-1
--
e37
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m39
0
infinite
0
--
heparan sulphate: lambda5: VpreB: Igalpha: Igbeta: preBCR: galectin-1
--
e38
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m40
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
heparan sulphate: lambda5: VpreB: Igalpha: Igbeta: preBCR
--
e41
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m43
0
infinite
0
--
heparan sulphate: lambda5: VpreB: Igalpha: Igbeta: preBCR
--
e42
cso30:c:Complex
cso30:i:CC_CellComponent
--
csml-variable:Double
m44
0
infinite
0
--
csml-variable:Double
m45
0
infinite
0
--
csml-variable:Double
m46
0
infinite
0
--
csml-variable:Double
m47
0
infinite
0
--
csml-variable:Double
m63
0
infinite
0
--
antigen
--
e49
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m64
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
antigen: tachykinin receptors
--
e63
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m65
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
PMID: 14962188 The first phase occurs once cells have productively rearranged the m-heavy chain (HC) and express the preB-cell receptor (preBCR).
PMID: 14962188, 7831294, 7964471, 11602642 Not only do progenitor B cells require IL-7 for efficient in vitro differentiation (3) but also to reach one of the earliest identifiable stages of B-cell development based on the expression of CD19.
p11
p11
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c24 : 1
1.0*0.1
nodelay
--
0
PMID: 14962188, 9022004, 7686307, 9495344 For example, IL-7 has been implicated in altering the expression of RAG proteins, targeting of the recombination machinery to specific Ig gene segments, and also by inducing signal transducers and activators of transcription-5 (STAT5)-dependent accessibility of the T-cell receptor (TCR) lambda locus.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m5*0.1
nodelay
--
0
PMID: 14962188 The activation of both the preBCR and the IL-7R can induce survival, proliferation, and differentiation of cells during the proB to preB-cell transition.
p13
p13
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c32 : 1
stoichiometry:c29 : 1
m24*m1767*0.1
nodelay
--
0
PMID: 14962188, 8589262, 9864155 Heparin and heparan sulfate have also been shown to influence the activity of IL-7.
p14
p14
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c30 : 1
stoichiometry:c33 : 1
stoichiometry:c31 : 1
m356124*m1767*0.1
nodelay
--
0
PMID: 14962188, 8589262, 9864155 Heparin and heparan sulfate have also been shown to influence the activity of IL-7.
p15
p15
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c64 : 1
m93367*m18*0.1
nodelay
--
0
PMID: 14962188, 7831294, 7964471, 11602642 Not only do progenitor B cells require IL-7 for efficient in vitro differentiation (3) but also to reach one of the earliest identifiable stages of B-cell development based on the expression of CD19. PMID: 14962188 The first phase occurs once cells have productively rearranged the m-heavy chain (HC) and express the preB-cell receptor (preBCR).
p16
p16
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c41 : 1
stoichiometry:c37 : 1
m129*m27*0.1
nodelay
--
0
PMID: 14962188, 10379911 Signaling pathways known to be activated by the IL-7R include the Janus kinase (JAK)/STAT cascade, the phosphoinositide 3-kinase (PI3K), and Ras-GTPase pathways.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c40 : 1
stoichiometry:c39 : 1
m29*m28*0.1
nodelay
--
0
PMID: 14962188, 10379911 Signaling pathways known to be activated by the IL-7R include the Janus kinase (JAK)/STAT cascade, the phosphoinositide 3-kinase (PI3K), and Ras-GTPase pathways.
p18
p18
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c43 : 1
stoichiometry:c44 : 1
m27*m32*0.1
nodelay
--
0
PMID: 14962188, 10379911 Signaling pathways known to be activated by the IL-7R include the Janus kinase (JAK)/STAT cascade, the phosphoinositide 3-kinase (PI3K), and Ras-GTPase pathways.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c46 : 1
stoichiometry:c47 : 1
m27*m34*0.1
nodelay
--
0
PMID: 14962188, 10379911 Signaling pathways known to be activated by the IL-7R include the Janus kinase (JAK)/STAT cascade, the phosphoinositide 3-kinase (PI3K), and Ras-GTPase pathways.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m22*0.1
nodelay
--
0
PMID: 14962188 Binding of IL-7 to the specific IL-7Ra chain leads to heterodimerization with the gammac chain.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c50 : 1
stoichiometry:c49 : 1
m34*m23*0.1
nodelay
--
0
PMID: 14962188 Ras is also activated by the preBCR.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c53 : 1
stoichiometry:c57 : 1
stoichiometry:c52 : 1
m35*m27*m37*0.1
nodelay
--
0
PMID: 14962188, 11672535 ERK is specifically activated following preB-cell stimulation with IL-7, and this activation can occur concurrently with ERK phosphorylation mediated by the preBCR. PMID: 14962188 pERK derived from preBCR signals can also contribute to the amount of activated ERK.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c56 : 1
stoichiometry:c55 : 1
m35*m23*0.1
nodelay
--
0
PMID: 14962188, 11672535 ERK is specifically activated following preB-cell stimulation with IL-7, and this activation can occur concurrently with ERK phosphorylation mediated by the preBCR.
p23
p23
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c59 : 1
stoichiometry:c63 : 1
stoichiometry:c60 : 1
m4508*m40*0.1
nodelay
--
0
PMID: 14962188, 12039909, 9233622, 8548286 The hypothesis that no ligand is required for preBCR function is supported by the finding that a variety of truncated preBCR constructs retain their function in the absence of most of the extracellular portion of the complex and/or the ability to bind SLCs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c68 : 1
stoichiometry:c62 : 1
m39*m44*0.1
nodelay
--
0
PMID: 14962188, 12271131 In humans, galectin-1 has been identified as a binding partner for the preBCR.
p25
p25
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c34 : 1
stoichiometry:c65 : 1
m20*m15*0.1
nodelay
--
0
PMID: 14962188 This interaction requires the unique tail of l5, which binds heparan sulfate as a ligand.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c67 : 1
m43*0.1
nodelay
--
0
PMID: 14962188, 1722112 heparin treatment of preBCR+ 70Z/3 cells induces internalization of the receptor.
PMID; 14962188, 8707854, 7812048, 10229831 Both B cells and stromal cells produce syndecan-1 and syndecan-4.
PMID; 14962188, 8707854, 7812048, 10229831 Both B cells and stromal cells produce syndecan-1 and syndecan-4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c71 : 1
m45*0.1
nodelay
--
0
PMID; 14962188, 8707854, 7812048, 10229831 Both B cells and stromal cells produce syndecan-1 and syndecan-4.
PMID: 14962188, 11062498 Hemokinin-1 (HK1) is produced by preB cells and acts in an autocrine or paracrine fashion at this critical checkpoint.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c72 : 1
m46*0.1
nodelay
--
0
PMID; 14962188, 8707854, 7812048, 10229831 Both B cells and stromal cells produce syndecan-1 and syndecan-4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c76 : 1
m47*0.1
nodelay
--
0
PMID: 14962188 Similar to other small bioactive peptides, tachykinins are generated through proteolytic cleavage of larger precursors called preprotachykinins (PPTs).
p32
p32
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c83 : 1
stoichiometry:c78 : 1
m72948*m7316*0.1
nodelay
--
0
PMID: 14962188 Recent studies by several groups have shown that HK1, when applied at different concentrations, leads to the activation of all three known receptors.
p33
p33
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c84 : 1
stoichiometry:c80 : 1
m3058*m7316*0.1
nodelay
--
0
PMID: 14962188 Recent studies by several groups have shown that HK1, when applied at different concentrations, leads to the activation of all three known receptors.
p34
p34
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c81 : 1
stoichiometry:c85 : 1
stoichiometry:c82 : 1
m3059*m7316*0.1
nodelay
--
0
PMID: 14962188 Recent studies by several groups have shown that HK1, when applied at different concentrations, leads to the activation of all three known receptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c86 : 1
m65*0.1
nodelay
--
0
PMID: 14962188, 2445815, 1706387 Production of Igs by B lymphocytes, for example, is enhanced by substance P following LPS or antigen stimulation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c88 : 1
stoichiometry:c92 : 1
stoichiometry:c87 : 1
m16*m65*0.1
nodelay
--
0
PMID: 14962188, 2445815, 1706387 Production of Igs by B lymphocytes, for example, is enhanced by substance P following LPS or antigen stimulation.
p37
p37
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c90 : 1
stoichiometry:c91 : 1
m3056*m64*0.1
nodelay
--
0
PMID: 14962188, 2445815, 1706387 Production of Igs by B lymphocytes, for example, is enhanced by substance P following LPS or antigen stimulation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m114303*0.1
nodelay
--
0
PMID: 14962188, 11062498 Hemokinin-1 (HK1) is produced by preB cells and acts in an autocrine or paracrine fashion at this critical checkpoint.
p5
p5
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c8 : 1
stoichiometry:c9 : 1
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c7 : 1
stoichiometry:c12 : 1
m2596*m2595*m13*m19*m23*0.1
nodelay
--
0
PMID: 14962188, 7688784 The preBCR complex includes surrogate lightchain (SLC) proteins l5 and VpreB and the signaling components Igalpha and Igbeta.
p6
p6
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c13 : 1
1.0*0.1
nodelay
--
0
PMID: 14962188, 9973461 For example, recombination-activating gene-2 (RAG2)-deficient proB cells exhibit higher levels of Bax, a pro-apoptotic mediator, and an increased Bax/Bcl2 ratio, consistent with elevated susceptibility to apoptosis.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c14 : 1
stoichiometry:c17 : 1
stoichiometry:c15 : 1
m93669*0.1
nodelay
--
0
PMID: 14962188, 9973461 For example, recombination-activating gene-2 (RAG2)-deficient proB cells exhibit higher levels of Bax, a pro-apoptotic mediator, and an increased Bax/Bcl2 ratio, consistent with elevated susceptibility to apoptosis.
p8
p8
cso30:i:ME_Translocation
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c18 : 1
stoichiometry:c19 : 1
m1767*0.1
nodelay
--
0
PMID: 14962188, 1372556, 7545464 IL-7 is a 25-kDa member of the hematopoietin family secreted by reticular stromal cells in the bone marrow, thymic cortical epithelial cells, as well as by other cell types.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c20 : 1
stoichiometry:c21 : 1
stoichiometry:c22 : 1
m1776*m21*0.1
nodelay
--
0
PMID: 14962188 In the absence of a signal mediated by IL-7 binding to its receptor, Band T-cell differentiation is severely impaired.
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--